Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-16CASI3Ownership Filing for Gao Wei RMEDIUM
Gao Wei R, General Counsel at CASI Pharmaceuticals, Inc., reported a change in ownership on March 18, 2026. The filing details the ownership of various stock options, all of which are exercisable and grant the right to buy Ordinary Shares. These options have varying expiration dates between 2031 and 2034, with exercise...
Nano CapBiotechnology
2026-04-16IMA3Form 3 Filing for ImageneBio, Inc. - Officer/Director Ownership
This filing is an initial statement of beneficial ownership of securities filed by Su Wei-guo, a director at ImageneBio, Inc. (IMA). The filing, dated April 16, 2026, indicates that the reporting owner has no securities owned. The reporting owner, Su Wei-guo, is identified with CIK 0002113925 and is associated with Ima...
Micro CapBiotechnology
2026-04-16DBVT3POWER OF ATTORNEY FOR SEC FILINGSMEDIUM
This document is a Power of Attorney filed by Philina Lee, a director of DBV Technologies S.A., appointing specific individuals at the company as her attorneys-in-fact. These attorneys are authorized to execute and file Forms 3, 4, and 5 with the SEC on her behalf, as required by Section 16(a) of the Securities Exchang...
Small CapBiotechnology